PL2467399T3 - Oczyszczanie vWF zwiększające usuwanie wirusów bez otoczki lipidowej - Google Patents

Oczyszczanie vWF zwiększające usuwanie wirusów bez otoczki lipidowej

Info

Publication number
PL2467399T3
PL2467399T3 PL10747134T PL10747134T PL2467399T3 PL 2467399 T3 PL2467399 T3 PL 2467399T3 PL 10747134 T PL10747134 T PL 10747134T PL 10747134 T PL10747134 T PL 10747134T PL 2467399 T3 PL2467399 T3 PL 2467399T3
Authority
PL
Poland
Prior art keywords
vwf
purification
enveloped viruses
increased removal
lipid enveloped
Prior art date
Application number
PL10747134T
Other languages
English (en)
Polish (pl)
Inventor
Artur Mitterer
Meinhard Hasslacher
Christa Mayer
Original Assignee
Baxalta Inc
Baxalta GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43063204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2467399(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxalta Inc, Baxalta GmbH filed Critical Baxalta Inc
Publication of PL2467399T3 publication Critical patent/PL2467399T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL10747134T 2009-08-20 2010-08-20 Oczyszczanie vWF zwiększające usuwanie wirusów bez otoczki lipidowej PL2467399T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23557009P 2009-08-20 2009-08-20
PCT/US2010/046180 WO2011022657A1 (en) 2009-08-20 2010-08-20 Purification of vwf for increased removal of non-lipid enveloped viruses
EP10747134.4A EP2467399B2 (en) 2009-08-20 2010-08-20 Purification of vWF for increased removal of non-lipid enveloped viruses

Publications (1)

Publication Number Publication Date
PL2467399T3 true PL2467399T3 (pl) 2016-05-31

Family

ID=43063204

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10747134T PL2467399T3 (pl) 2009-08-20 2010-08-20 Oczyszczanie vWF zwiększające usuwanie wirusów bez otoczki lipidowej

Country Status (18)

Country Link
US (1) US9315560B2 (en, 2012)
EP (1) EP2467399B2 (en, 2012)
JP (1) JP5838159B2 (en, 2012)
KR (1) KR101894600B1 (en, 2012)
CN (2) CN106008697B (en, 2012)
AU (1) AU2010284116B9 (en, 2012)
BR (1) BR112012003802B1 (en, 2012)
CA (1) CA2771232A1 (en, 2012)
DK (1) DK2467399T3 (en, 2012)
ES (1) ES2562256T5 (en, 2012)
HU (1) HUE026907T2 (en, 2012)
IN (1) IN2012DN01849A (en, 2012)
MX (1) MX2012002129A (en, 2012)
NZ (1) NZ598249A (en, 2012)
PL (1) PL2467399T3 (en, 2012)
PT (1) PT2467399E (en, 2012)
SG (2) SG10201408106WA (en, 2012)
WO (1) WO2011022657A1 (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
PL2349314T3 (pl) * 2008-10-21 2013-07-31 Baxalta Inc Formulacje liofilizowanego rekombinowanego VWF
MY173835A (en) * 2012-06-21 2020-02-24 Baxter Int Virus filtration of cell culture media
JP6320429B2 (ja) * 2013-02-22 2018-05-09 エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ 負帯電粒子を用いるウイルス調製物のクロマトグラフィー精製
ES2895798T3 (es) * 2014-06-06 2022-02-22 Octapharma Ag Preparación que comprende péptidos del factor VIII y del factor Von Willebrand
WO2015188224A1 (en) 2014-06-13 2015-12-17 Csl Limited Improved production of recombinant von willebrand factor in a bioreactor
EP3672644A1 (en) 2017-08-23 2020-07-01 CSL Behring GmbH Method for virus filtration of von willebrand factor
US10934340B2 (en) 2018-03-21 2021-03-02 Baxalta Incorporated Separation of VWF and VWF propeptide by chromatographic methods
EP4490042A1 (en) 2022-03-08 2025-01-15 Equashield Medical Ltd. Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
WO1986006096A1 (en) 1985-04-11 1986-10-23 The Children's Medical Center Corporation Von willebrand factor
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406373B (de) * 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
US6531577B1 (en) 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
ATE321066T1 (de) * 1998-05-06 2006-04-15 Genentech Inc Anti-her2 antikörperzusammensetzung
WO2006071801A2 (en) 2004-12-27 2006-07-06 Baxter International Inc Polymer-von willebrand factor-conjugates

Also Published As

Publication number Publication date
EP2467399B2 (en) 2023-02-01
AU2010284116A1 (en) 2012-03-08
US9315560B2 (en) 2016-04-19
ES2562256T5 (es) 2023-07-20
EP2467399B1 (en) 2015-11-11
BR112012003802A2 (pt) 2016-11-22
WO2011022657A1 (en) 2011-02-24
BR112012003802B1 (pt) 2022-10-25
KR20120065342A (ko) 2012-06-20
JP5838159B2 (ja) 2015-12-24
CN106008697B (zh) 2020-08-04
SG10201408106WA (en) 2015-01-29
CA2771232A1 (en) 2011-02-24
DK2467399T3 (en) 2017-01-23
MX2012002129A (es) 2012-06-08
CN106008697A (zh) 2016-10-12
PT2467399E (pt) 2016-03-18
SG178478A1 (en) 2012-04-27
AU2010284116B2 (en) 2015-02-12
IN2012DN01849A (en, 2012) 2015-08-21
US20110092681A1 (en) 2011-04-21
CN102482341A (zh) 2012-05-30
EP2467399A1 (en) 2012-06-27
NZ598249A (en) 2014-04-30
HUE026907T2 (en) 2016-07-28
ES2562256T3 (es) 2016-03-03
JP2013502434A (ja) 2013-01-24
AU2010284116B9 (en) 2015-03-26
KR101894600B1 (ko) 2018-09-03

Similar Documents

Publication Publication Date Title
PT2467399E (pt) Purificação do vwf para remoção melhorada de vírus sem envelope lipídico
EP2334328A4 (en) METHOD FOR CLEANING VIRUSES
ZA201102552B (en) Viral inactivation during purification of antibodies
IL214434A0 (en) Purification of immunoglobulins
PL3192874T3 (pl) Oczyszczanie wirusa
GB0922142D0 (en) Regeneration of absorption solution
IL214374A (en) Deptomycin purification process
IL228609A0 (en) Sustained release silver compound for water purification
SG10201703576WA (en) Oral formulations for promoting cellular purification
IL226926B (en) Elimination of viral activity through the use of an improved solvent-detergent method
EP2634142A4 (en) PROCESS FOR THE PURIFICATION OF CHLOROSILANES
PL2417251T3 (pl) Sposób oczyszczania wirusa wścieklizny
PT2598516E (pt) Processo de purificação de proteínas
IL243248A0 (en) Purification method
EP2471740A4 (en) PROCESS FOR PURIFYING CHLORINEILANE
GB0922140D0 (en) Regeneration of absorption solution
EP2501651A4 (en) PROCESS FOR PURIFYING MONOSILANE
EP2519537A4 (en) CLEANING PROTEINS
ZA201302573B (en) Method for purification of complement factor h
ZA201300320B (en) Purification process
EP2465819A4 (en) PROCESS FOR CLEANING CHLORINEILANES
GB201004372D0 (en) Compounds for purification
PL2585230T3 (pl) Czyszczenie urządzeń do alkilowania katalizowanego HF
GB0906674D0 (en) Regeneration of heat
GB0916016D0 (en) Inactivation of pathogens